InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Emerson Erik C.. Director active across 1 company, notably Apimeds Pharmaceuticals US, Inc.. Aggregated, 1 filings have been recorded. History available since 16 May 2025. The latest transaction was filed on 16 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration